학술논문
CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.
Document Type
Article
Author
Brault, Julie; Liu, Taylor; Siyuan Liu; Lawson, Amanda; Uimook Choi; Nikita Kozhushko; Bzhilyanskaya, Vera; Pavel-Dinu, Mara; Meis, Ronald J.; Eckhaus, Michael A.; Burkett, Sandra S.; Bosticardo, Marita; Kleinstiver, Benjamin P.; Notarangelo, Luigi D.; Lazzarotto, Cicera R.; Tsai, Shengdar Q.; Xiaolin Wu; Dahl, Gary A.; Porteus, Matthew H.; Malech, Harry L.
Source
Frontiers in Immunology; 1/4/2023, Vol. 13, p01-15, 15p
Subject
Language
ISSN
16643224
Abstract
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)